Ireland
--:--IST
Latest
Airmid Éireann 1.4 Puts Irish Pharma Data in Global Context Northern Ireland Phone Switch-Off: Check Medical Devices Irish Medtech Calls for MDR and IVDR Reform at Galway Event Clonmel Healthcare Launches Mabelle Menocare Supplements HealthSpan Partners to Acquire Irish GP Group Centric Health Outpatient Waiting List Reaches 692,524, Up 10.5% in a Year Airmid Éireann 1.4 Puts Irish Pharma Data in Global Context Northern Ireland Phone Switch-Off: Check Medical Devices Irish Medtech Calls for MDR and IVDR Reform at Galway Event Clonmel Healthcare Launches Mabelle Menocare Supplements HealthSpan Partners to Acquire Irish GP Group Centric Health Outpatient Waiting List Reaches 692,524, Up 10.5% in a Year
Clinical Trials in France / NCT04199403
Recruiting Observational

Assessment of Complication Risk Factors in a French National Cohort of Asplenic Patients

NCT04199403 · tracked via the Priya Life Science France tracker
Sponsor
Poitiers University Hospital
Phase
Observational
Started
2020-01-09
Last updated
2026-07-16

Condition(s) studied

Asplenia

Study summary

Spleen could have been surgically removed for trauma, cancer, auto-immune disease, or to perform a diagnosis. Spleen could be non-functional due to radiotherapy or splenic artery embolism. These patients are at risks of infectious diseases due to encapsulated bacteria, cancer, and thromboembolism disease. The purpose of this study is to assess complications occurring in French patients without spleen and to implement new diagnostic tools for follow-up.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * ≥18 year-old * With asplenia due to splenectomy, splenic artery embolization or radiotherapy Exclusion Criteria: * Genetic asplenia including sick cell disease

Primary outcome measure(s)

  • Assessment of complication risk factors — 3 years
    Comparison between splenectomy and other type of asplenia for prevalence of infectious diseases, cancer, and thromboembolism disease

Trial sites (12)

FacilityCityRegionStatus
C.H. d'Angoulême Angoulême France Recruiting
C.H. Victor Dupouy Argenteuil France Recruiting
C.H. de Béthune Béthune France Withdrawn
Hôpitaux de Chartres Chartres France Active Not Recruiting
C.H.U. de Lille Lille France Recruiting
C.H.U. de Montpellier Montpellier France Recruiting
Hôtel-Dieu - CHU de Nantes Nantes France Recruiting
C.H.U. de Poitiers Poitiers France Recruiting
C.H.U. de Rouen Rouen France Not Yet Recruiting
C.H.U. de Toulouse Toulouse France Recruiting
C.H. de Tourcoing Tourcoing France Recruiting
C.H. de Valenciennes Valenciennes France Recruiting

More Poitiers University Hospital trials in France

What is the Role of the Exposome in Pulmonary Hypertension Starting soon
Weaning From High Flow Nasal Oxygen in Acute Respiratory Failure : a Target Trial Emulation Active, not recruiting
CAR-T Immunomonitoring in Multiple Myeloma (CART I5M) Recruiting
Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial Recruiting
Interventions to Remedy the Negative Effects of Obesity Stigma Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04199403 on ClinicalTrials.gov ↗ ← All trials in France